SPOTLIGHT -
Dr. Ayers on the Evolving Treatment Landscape in CLL
Emily C. Ayers, MD, hematologist/oncologist, assistant professor, University of Virginia Health, discusses the evolving treatment landscape in chronic lymphocytic leukemia.
Read More
Dr. Ayers on Trials Examining Venetoclax in CLL
Emily C. Ayers, MD, discusses recent trials examining the use of venetoclax in patients with chronic lymphocytic leukemia.
Dr. Ayers on Recent Developments in CLL
Emily C. Ayers, MD, discusses recent developments in chronic lymphocytic leukemia.
Dr. Ayers on Unmet Needs in CLL
Emily C. Ayers, MD, discusses unmet needs in chronic lymphocytic leukemia.
Second-Line Treatment of R/R LBCL With Lisocabtagene Maraleucel (Liso-cel)
ZUMA-7: Axicabtagene Ciloleucel as a Second-Line Therapy for LBCL
Currently Available Treatment Options for Patients With R/R DLBCL
Overview of Relapsed/Refractory Diffuse Large B-Cell Lymphoma (R/R DLBCL)
